CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022		12,292,104
Beginning balance at Dec. 31, 2022	$ 31,321,994	$ 12,292	$ 84,189,965	$ (40,834,721)	$ (12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	479,641		479,641
Stock grant program vesting (in shares)		96,285
Stock grant program vesting	0	$ 96	(96)
Stock issued for contingent consideration (in shares)		64,224
Stock issued for contingent consideration	191,919	$ 64	191,855
Net loss	(5,251,201)			(5,251,201)
Ending balance (in shares) at Mar. 31, 2023		12,452,613
Ending balance at Mar. 31, 2023	26,742,353	$ 12,452	84,861,365	(46,085,922)	(12,045,542)
Beginning balance (in shares) at Dec. 31, 2022		12,292,104
Beginning balance at Dec. 31, 2022	31,321,994	$ 12,292	84,189,965	(40,834,721)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(11,015,110)
Ending balance (in shares) at Jun. 30, 2023		13,056,409
Ending balance at Jun. 30, 2023	22,893,674	$ 13,056	86,775,991	(51,849,831)	(12,045,542)
Beginning balance (in shares) at Mar. 31, 2023		12,452,613
Beginning balance at Mar. 31, 2023	26,742,353	$ 12,452	84,861,365	(46,085,922)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	622,547		622,547
Stock grant program vesting (in shares)		86,020
Stock grant program vesting	0	$ 86	(86)
Stock issued for contingent consideration (in shares)		517,776
Stock issued for contingent consideration	1,292,683	$ 518	1,292,165
Net loss	(5,763,909)			(5,763,909)
Ending balance (in shares) at Jun. 30, 2023		13,056,409
Ending balance at Jun. 30, 2023	$ 22,893,674	$ 13,056	86,775,991	(51,849,831)	(12,045,542)
Beginning balance (in shares) at Dec. 31, 2023	12,072,836	13,522,669
Beginning balance at Dec. 31, 2023	$ 10,085,355	$ 13,523	88,389,756	(66,272,382)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	656,576		656,576
Stock grant program vesting (in shares)		245,925
Stock grant program vesting	0	$ 246	(246)
Net loss	(2,560,563)			(2,560,563)
Ending balance (in shares) at Mar. 31, 2024		13,768,594
Ending balance at Mar. 31, 2024	$ 8,181,368	$ 13,769	89,046,086	(68,832,945)	(12,045,542)
Beginning balance (in shares) at Dec. 31, 2023	12,072,836	13,522,669
Beginning balance at Dec. 31, 2023	$ 10,085,355	$ 13,523	88,389,756	(66,272,382)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (5,525,291)
Ending balance (in shares) at Jun. 30, 2024	12,562,466	14,012,299
Ending balance at Jun. 30, 2024	$ 5,806,560	$ 14,012	89,635,763	(71,797,673)	(12,045,542)
Beginning balance (in shares) at Mar. 31, 2024		13,768,594
Beginning balance at Mar. 31, 2024	8,181,368	$ 13,769	89,046,086	(68,832,945)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	460,785		460,785
Stock grant program vesting (in shares)		172,558
Stock grant program vesting	0	$ 172	(172)
Stock issued for contingent consideration (in shares)		71,147
Stock issued for contingent consideration	129,135	$ 71	129,064
Net loss	$ (2,964,728)			(2,964,728)
Ending balance (in shares) at Jun. 30, 2024	12,562,466	14,012,299
Ending balance at Jun. 30, 2024	$ 5,806,560	$ 14,012	$ 89,635,763	$ (71,797,673)	$ (12,045,542)